Statistics for Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection
Total visits
| views | |
|---|---|
| Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection | 126 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1531165.pdf | 434 |
| java.util.UUID:ec8c42d7-1760-4c9c-84a8-c14f565af896 | 78 |
| java.util.UUID:8b787fcd-106d-4c03-be36-d6fb1832bdac | 8 |
| java.util.UUID:1ef9605c-fa57-4541-8b9e-cc5bdb0d6c4c | 3 |
Top country views
| views | |
|---|---|
| United States | 103 |
| Canada | 2 |
| China | 2 |
| Russia | 2 |
| Sweden | 2 |
| Czechia | 1 |
| France | 1 |
| Iran | 1 |
| South Korea | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 51 |
| Fairfield | 9 |
| White Plains | 9 |
| Cambridge | 6 |
| Houston | 6 |
| San Francisco | 4 |
| Ann Arbor | 2 |
| Toronto | 2 |
| Beijing | 1 |
| Chelyabinsk | 1 |
| Chicago | 1 |
| Lebanon | 1 |
| Monmouth Junction | 1 |
| Moscow | 1 |
| Nanterre | 1 |
| Pittsburgh | 1 |
| Seremban | 1 |
| Slapanice | 1 |
| Stockholm | 1 |
| Tehran | 1 |
| Tustin | 1 |